The rationale of this study is to conduct a summative (i.e., validation) usability test of Ciprofloxacin Dry Powder for Inhalation (DPI) and the associated Instructions for Use.

Inclusion Criteria

• Subjects (male and female) with non-cystic fibrosis bronchiectasis (NCFB) or chronic obstructive pulmonary disease (COPD)
• Subjects must be aged ≥40
• Subject must be able to independently manage and administer their NCFB/COPD medications

Exclusion Criteria:

• Subjects with recent exacerbation
• Subjects with recent significant hemoptysis in the four weeks before screening (and/or during the screening period)
• Subjects allergic to quinine
• Known chronic bronchial asthma